Stocks making the biggest moves midday: Starbucks, CarMax, Virgin Galactic and more

Check retired the companies making headlines successful midday trading.

Starbucks — Starbucks shares mislaid astir 3% aft a national representing workers said strikes are slated to statesman Friday successful effect to claims that its not allowing Pride decorations astatine cafes. More than 150 stores, and astir 3,500 workers, program to articulation the onslaught occurring implicit the adjacent week, the national said.

CarMax — The utilized car retailer popped 8.8% aft beating the statement estimation of analysts for its first-quarter revenue. CarMax posted $7.69 billion, higher than the $7.49 cardinal anticipated by analysts polled by StreetAccount.

Virgin Galactic — Virgin Galactic shed 18% after announcing a $300 cardinal superior rise via a communal banal offering. The abstraction tourism institution besides said it plans to rise an further $400 cardinal to turn its fleet of spacecrafts.

C3.ai — Shares of the large artificial quality beneficiary sank much than 11% aft Deutsche Bank reiterated its merchantability rating connected the heels of the company's capitalist day. "Until we get much comfortableness successful immoderate of the starring indicators, magnitude of caller deals and signs of sustained caller concern traction we support our Sell rating," the slope said.

Under Armour — The diversion covering company's banal dropped 3.2% aft being downgraded by Wells Fargo to adjacent value from overweight. The Wall Street slope said Under Armour had overexposure to North America, excess inventory and CEO astatine the helm for conscionable six months.

Accenture — Shares of the It and consulting steadfast fell 1.7% connected Friday, connected way for their fifth-straight losing session. TD Cowen downgraded Accenture to marketplace execute from outperform, citing a tepid outlook from the institution successful its net study earlier this week.

Evotec SE — Shares of the cause improvement institution based successful Germany gained 3% pursuing an upgrade to overweight from adjacent value by analysts astatine Morgan Stanley. The steadfast said Evotec looks good positioned to capitalize connected artificial intelligence.

GSK — U.S-listed shares of the U.K.-based biopharmaceutical institution gained 5% GSK announced the archetypal ineligible colony implicit allegations that its Zantac heartburn medicine causes cancer.

— CNBC's Michelle Fox, Alex Harring and Jesse Pound contributed reporting